Workers sit outside of D.C. Health's first monkeypox vaccination clinic, which is administering the first Jynneos vaccine doses distributed in the U.S. capital, in Washington, U.S., June 28, 2022.
REUTERS/Gavino GarayWASHINGTON, Sept 28 (Reuters) - At risk people nationwide will now be able to get Bavarian Nordic's (BAVA.CO) Jynneos monkeypox vaccine before being exposed to the disease, U.S. Centers for Disease Prevention and Control (CDC) Director Rochelle Walensky said on Wednesday.
At risk individuals will now be eligible to receive the vaccine before exposure as the CDC shifts to a Pre-Exposure Prophylaxis (PrEP) strategy, Wallensky said.
Monkeypox is transmitted through close contact with an infected person, such as via sexual activity, or with the skin blisters associated with the disease.
People with jobs that put them at risk of exposure, such as healthcare workers, were already eligible for vaccination against monkeypox.